82448-134-42 : NDC 2026 Code

82448-134-42 : Mirdametinib ( Gomekli )

Additionally :

You can get information about “82448-134-42” NDC code in 82448-134-42 in HTML format

HTML | 82448-134-42 in TXT (Plain Text) format

TXT | 82448-134-42 in PDF (Portable Document Format)

PDF | 82448-134-42 in XML format

XML formats.

NDC Code : 82448-134-42 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "82448-134-42",
    "PackageDescription": "42 TABLET, FOR SUSPENSION in 1 BOTTLE (82448-134-42) ",
    "NDC11Code": "82448-0134-42",
    "ProductNDC": "82448-134",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Gomekli",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Mirdametinib",
    "DosageFormName": "TABLET, FOR SUSPENSION",
    "RouteName": "ORAL",
    "StartMarketingDate": "20250211",
    "EndMarketingDate": null,
    "MarketingCategoryName": "NDA",
    "ApplicationNumber": "NDA219379",
    "LabelerName": "SpringWorks Therapeutics, Inc.",
    "SubstanceName": "MIRDAMETINIB",
    "StrengthNumber": "1",
    "StrengthUnit": "mg/1",
    "Pharm_Classes": "Kinase Inhibitor [EPC], Mitogen-Activated Protein Kinase Kinase 1 Inhibitors [MoA], Mitogen-Activated Protein Kinase Kinase 2 Inhibitors [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-11-08",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20250211",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}